FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 3053168 · Received April 11, 2013

Report

Report Number
2124215-2013-04498
Event Type
Injury
Date Received
April 11, 2013
Date of Event
March 7, 2013
Report Date
April 9, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THIS DEVICE WAS THOROUGHLY EVALUATED. VISUAL INSPECTION OF THE DEVICE HEADER AND CASE DID NOT REVEAL ANY ANOMALIES. IT WAS CONFIRMED THAT THE DEVICE HAD NO TELEMETRY AND A MEMORY DOWNLOAD COULD NOT BE PERFORMED. THE DEVICE CASE WAS OPENED IN ORDER TO ASSESS THE INTERNAL COMPONENTS. INITIAL ELECTRICAL TESTING REVEALED THAT THE TRANSFORMER HAD FAILED, RESULTING IN ELECTRICAL OVERSTRESS DAMAGE TO THE POWER SUPPLY CIRCUITRY. DETAILED ANALYSIS DETERMINED THE INABILITY TO INTERROGATE THIS DEVICE WAS DUE TO THE ELECTRICAL OVERSTRESS DAMAGE. THIS RESULTED IN A HIGH CURRENT DRAIN, WHICH DEPLETED THE BATTERY MORE QUICKLY THAN EXPECTED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) COULD NOT BE INTERROGATED. VARIOUS TROUBLESHOOTING TECHNIQUES WERE ATTEMPTED BUT WERE UNSUCCESSFUL. AN INVASIVE PROCEDURE WAS PERFORMED. THE DEVICE WAS EXPLANTED AND SUCCESSFULLY REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156524 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 55 YR Hospitalization| L| R 0157| E102